e-learning
resources
Vienna 2003
Monday 29.09.2003
Similarities and differences between β-2 agonists
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is flow dependent dose delivery of a salbutamol-Turbuhaler clinically relevant in asthma patients?
M. E. A. C. Broeders, J. Schalkwijk, J. Molema, H. T. M. Folgering (Groesbeek, The Netherlands)
Source:
Annual Congress 2003 - Similarities and differences between β-2 agonists
Session:
Similarities and differences between β-2 agonists
Session type:
Thematic Poster Session
Number:
1840
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. E. A. C. Broeders, J. Schalkwijk, J. Molema, H. T. M. Folgering (Groesbeek, The Netherlands). Is flow dependent dose delivery of a salbutamol-Turbuhaler clinically relevant in asthma patients?. Eur Respir J 2003; 22: Suppl. 45, 1840
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
A realistic study assessing inhaled treatment compliance in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001
Volume response are more significant and important than flow response to bronchodilator in patients with COPD
Source: Annual Congress 2009 - Accuracy in lung function testing
Year: 2009
Do different combinations of bronchodilator therapies have different effects on health status in patients with COPD?
Source: Eur Respir J 2003; 22: Suppl. 45, 52s
Year: 2003
COPD exacerbation: resolution of symptoms after starting antibiotic treatment was unaltered by the timing of therapy but was dependent on baseline gas transfer
Source: Annual Congress 2008 - Management of COPD
Year: 2008
Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Patients with COPD prescribed inhaled corticosteroid in primary care – Time for re-assessment based on exacerbation rate and blood eosinophils?
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020
What constitutes a “clinically significant” bronchodilator response in children?
Source: Eur Respir J, 55 (5) 2000207; 10.1183/13993003.00207-2020
Year: 2020
What influences the response to training of inhalation technique in patients with asthma and COPD?
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018
Resource utilization and economic impact of switching uncontrolled asthma and exacerbating COPD patients on monotherapy to fixed dose combination treatment in Germany
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012
Spanish consensus on the characteristics of severe asthmatic patients under biological treatment suitable for at home administration
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Exposure-response analysis of tezepelumab in patients with severe asthma to guide phase 3 dose selection
Source: International Congress 2018 – Asthma management
Year: 2018
COPD patients’ experience of long-term domestic oxygen-enriched nasal high flow treatment: A qualitative study.
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020
Influence of gender on health status response to long-term oxygen therapy in very severe COPD patients
Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients
Year: 2009
A clinically significant bronchodilator response in children: how should it be measured?
Source: Eur Respir J, 55 (5) 2000636; 10.1183/13993003.00636-2020
Year: 2020
Frequency of acute flow and volume responses to bronchodilator administration in patients with COPD
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007
Can the use of adaptive aerosol delivery technology increase the quality of life for patients with COPD?
Source: Eur Respir J 2007; 30: Suppl. 51, 611s
Year: 2007
How often do asthma patients claim prescribed therapy?
Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS
Year: 2017
Does azithromycin-prednisolone combination therapy have additive effects than single therapy in patients with persistent asthma?
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009
The influence of smoking on the treatment response in patients with asthma
Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Year: 2007
Distribution of technetium-99m-labelled QVARTM delivered using an AutohalerTM device in children
Source: Eur Respir J 2003; 21: 1007-1011
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept